Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

FREYR Battery Announces Appointments to Senior Management and Board of Directors

Previous Microsoft executive Birger Steen appointed Chief Executive Officer and to Board of Directors; Co-founder and CEO Tom Einar Jensen appointed Executive Chair of Board of Directors; Founder and Executive Chair Torstein Dale Sjøtveit retiring as part of succession planNEW YORK & OSLO, Norway & LUXEMBOURG--FREYR Battery (NYSE: FREY) (“FREYR”), a developer of clean, next-generation battery cell production capacity, has announced two appointments to strengthen the company’s leadership capabilities and accelerate key strategic initiatives. The appointments to the senior management and

FREYR Battery Reports Second Quarter 2023 Results

NEW YORK & OSLO, Norway & LUXEMBOURG--FREYR Battery (NYSE: FREY) (“FREYR” or the “Company”), a developer of clean, next-generation battery cell production capacity, today reported financial results for the second quarter of 2023.  Highlights of the Second Quarter 2023 and Subsequent Events: · In a separate press release published this morning and available on FREYR’s website, FREYR announced appointments to the Company’s senior management team and Board of Directors in accordance with an established succession plan. Former Microsoft executive Birger Steen has been appointed as

BE Group is conducting a review of the organization for increased efficiency and a strengthened customer offering

In order to increase efficiency and to close the gap between BE Group's customers and management, a review of the organization is ongoing. As a result of this, an agreement has been made with the current MD for the Swedish operations, Magnus Bosson, who will leave the company during this quarter. Given the current Group structure with a focus on the Nordic customers primarily in Sweden and Finland, Peter Andersson, President and CEO of BE Group, will also assume the role as MD for the Swedish operations. “Magnus has during his time at BE Group contributed positively to the company’s

Nordic Aqua Partners – Invitation to presentation of Q2 2023 results

Nordic Aqua Partners will release its Q2 2023 results on Thursday, 17 August 2023 at 7:00 a.m. CEST. The report and presentation will be made available on the company’s website and on Newsweb. CEO Ragnar Joensen, CFO Hjalti Hvítklett and Chairman of Nordic Aqua Ningbo Ove Nodland will present the results by webcast the same day at 10:00 a.m. CEST. The webcast can be accessed at www.nordicaquapartners.com, or with the following link: https://bit.ly/Q2NOAP23 For further information please contact: Hjalti Hvítklett, CFO Nordic Aqua Partnershjalti@nordicaquapartners.com+298

Announcement from extraordinary general meeting in Readly International AB (publ)

Extraordinary general meeting in Readly International AB (publ) ("Readly" or the "Company") was held today on 10 August 2023 at 10:00 (CEST) at the Company’s premises, Kungsgatan 17 in Stockholm, and the following resolutions were passed by the meeting.Publisher agreement with Bonnier News AB, publisher agreement with Bonnier Publications International AS and advertising agreement with Bonnier News AB (related party transactions)The extraordinary general meeting resolved to approve a) publisher agreement with Bonnier News AB, b) publisher agreement with Bonnier Publications International

Paindrainer AB´s digital tool is the first device targeting chronic pain to receive FDA registration approval as a Medical Device Class 1

MEDICON VILLAGE, LUND, SWEDEN – Paindrainer AB is pleased to announce that the company’s 360° patient-centric[©] app (Paindrainer® PD1) has received registration approval as a Medical Device Class 1 (510k exemption) by the U.S. Food and Drug Administration (FDA).A Medical Device Class 1 falls under the low risk category according to the FDA classification system, which was also in line with the absent of risk observed in the most recent multi-center trial in the US. "We are thrilled to share this significant achievement and milestone that the Paindrainer® App, as the first self-

Elicera Therapeutics publishes a scientific article in Nature Communications about the CAR T construct in the ELC-401 program

Gothenburg, August 10, 2023 - Elicera Therapeutics AB (publ) (“Elicera”), a clinical stage cell and gene therapy company developing next-generation therapies based on oncolytic viruses and CAR T-cells armed with bystander immune activating properties using the company’s commercially available platform iTANK, today announced the publication of a scientific article in the prestigious journal, Nature Communications, describing the CAR T construct in the ELC-401 program.The publication entitled "Complementarity-determining region clustering may cause CAR-T cell dysfunction"

TORM plc to announce second quarter and first half 2023 results on 17 August 2023

TORM plc (“TORM”) (ticker: TRMD A on Nasdaq in Copenhagen and TRMD on Nasdaq in New York) will release its financial results for the second quarter and first half of 2023 on Thursday, 17 August 2023.   TORM’s results will be presented on a live webcast via TORM’s website at 09:00 am Eastern Time / 03:00 pm Central European Time. Participants should register at least ten minutes prior to the event. The webcast can be accessed via our website.    There will be a simultaneous conference call. For participation in the call, please dial

AFRY to provide consultancy services for the development of up to 1200 MW onshore wind power projects in the Baltics

As a result of an international tender process, Latvenergo AS, the Latvian state electricity company and the largest energy utility in the Baltic States, have awarded BLIX, part of AFRY, as the Owner's Engineer for the development of several large-scale onshore wind projects over a five-year period.In line with their vision to be the leading provider of sustainable solutions in the energy industry, Latvenergo is developing several onshore wind energy projects across the Baltics to reach a total capacity up to 1200 MW by 2030. Once all the projects in the pipeline are completed, the new

Roxtec upgrades to IFS Cloud to drive efficiencies and reduce costs

ERP solution will enable Swedish sealing solutions specialist to remain evergreen and add new functionality as and when requiredLondon, UK, August 10, 2023 – IFS , the global cloud enterprise software company, today announced that Roxtec International, a Swedish modular pipe and cable sealing systems company, has chosen to upgrade its existing IFS enterprise resource planning (ERP) software to the latest IFS Cloud™ solution to drive its ongoing global growth. Roxtec already uses IFS software to support its daily operations end-to-end, enabling it to benefit from

Invitation to investor presentation – second quarter 2023

Starbreeze AB will publish its interim report for the second quarter 2023 on Thursday, August 17, at 07.30 CEST. On the same day, the company will hold a webcast at 11.00 CEST. Tobias Sjögren, CEO, and Mats Juhl, CFO, will present the interim report for the second quarter 2023. In connection to the presentation there will be an opportunity to ask questions, or send in your questions ahead of time here . WebcastTime: Thursday, August 17, 11.00 CESTParticipation: To join the presentation – click here (

Invitation to Nanoform’s Q2 2023 Interim Report

Press release Nanoform Finland Plc August 10, 2023 11:00 a.m. Finnish time / 10:00 a.m. Swedish time Invitation to Nanoform’s Q2 2023 Interim Report Helsinki, Finland – Nanoform Finland Plc (“Nanoform”), an innovative nanoparticle medicine  enabling company, will publish its Q2 2023 interim report on August 24, 2023, at 8.10 a.m. Finnish time / 7.10 a.m. Swedish time. The company will hold an online presentation and conference call the same day at 3.00 p.m. Finnish time / 2.00 p.m. Swedish time. Nanoform will be represented by CEO Edward Hæggström, CFO Albert Hæggström and

SimCorp A/S - Major shareholder announcement

With reference to Section 30 of Consolidated Act no. 41 of 13 January 2023 on capital markets, please be informed that SimCorp A/S on August 9, 2023, was informed by UBS Group that UBS Group owns 9.28% of the share capital and voting rights in SimCorp A/S.The shares are traded at NASDAQ Copenhagen A/S. Questions may be addressed to Michael Bjergby, Chief Financial Officer, SimCorp A/S (+45 3544 8800). Company announcement no. 19/2023 SimCorp A/S

Musti Group’s financial reporting and AGM in financial year 2024

Musti Group plc                                                             Stock Exchange Release 10 August 2023 at 10.00 a.m. Musti Group’s financial reporting and AGM in financial year 2024 The calendar for Musti Group’s financial reporting concerning the financial year 2024 is as follows:  - 9 November 2023: Financial Statements Release for financial year 2023 - 15 December 2023: The Financial Statements and the Board of Directors’ Report for financial year 2023, Corporate Governance Statement, Non-Financial Information Report and the Remuneration Report - 1 February 2024:

Aiforia to publish Half-Year Financial Report for January–June 2023 on 25 August 2023

Aiforia Technologies Plc, Press Release, 10 August 2023 at 10:00 a.m. EEST. Aiforia will publish its Half-Year Financial Report for January–June 2023 on Friday, 25 August 2023, at around 9.00 a.m. EEST.After publication, the financial statements will be available on the company's website at https://investors.aiforia.com/.   Aiforia will host a webcast event at 10:00 a.m. EEST on the same day. The event will be chaired by CEO Jukka Tapaninen and will include a review to the company's financial performance and the progress of its strategy during the reporting period.   The event

Invitation to Sensys Gatso’s presentation of the Interim Report for Q2 and the first half-year 2023

Sensys Gatso Group, a global leader in traffic safety solutions, publishes the financial report for the second quarter and first half-year 2023 at 8.30 am CET on Thursday August 17 and hereby invites to a presentation/audiocast at 10 am CET. The company’s CEO Ivo Mönnink and CFO Simon Mulder will present the financial results in English.The presentation/audiocast can be joined online or via telephone and will be available on the company’s webpage https://www.sensysgatso.com If you wish to participate via webcast please use the link below.https://ir.financialhearings.com/sensys-gatso-

NORDEN initiates share buy-back programme

ANNOUNCEMENT NO. 112 - 10 AUGUST 2023 The Board of Directors has decided to carry out a share buy-back of up to a total of USD 30 million (approximately DKK 204 million). The share buy-back programme is initiated pursuant to the authorisation granted to the Board of Directors, which entitles NORDEN to acquire treasury shares at a nominal value not exceeding 10% of the share capital at the market price applicable at the time of acquisition with a deviation of up to 10%. This authorisation was granted at NORDEN’s general meeting on 9 March 2023.   Purpose The purpose of the share

Magnus Öhman Appointed Adjunct Board Member to Realheart

Press Release August 10, 2023 The nomination committee in Scandinavian Real Heart AB proposes that Magnus Öhman is elected to the board at the next general meeting. Until then, he will be an adjunct to the board. Magnus Öhman has extensive experience from the medical technology industry, including as CEO of St. Jude Medical's Swedish subsidiary within Cardiac Rhythm Management.The Swedish subsidiary in Cardiac Rhythm Management (CRM) had at the end of Magnus Öhman's time as CEO over 620 employees, of which 200 in research and development, and sales of over SEK 5 billion, of which SEK 900

Veidekke: Invitation to presentation of Q2 2023 results 17 August 2023

Veidekke ASA will report second quarter 2023 results on Thursday 17 August 2023 at 07:00 CET. The report and presentation will be made available at the same time on veidekke.com. A presentation of the quarterly results will be held at 08:30 CET at Veidekke’s head office in Skabos vei 4 at Skøyen in Oslo. All presentations will be held in Norwegian. Presentations and ensuing Q&A will be webcast on veidekke.com. Veidekke welcomes questions to the presenters from the audience present or via web.

NORDEN reports net profit of USD 108 million in Q2 2023 and continues to return cash to shareholders

ANNOUNCEMENT NO. 111 - 10 AUGUST 2023 For Q2 2023, NORDEN reports a profit of USD 108 million (approx. DKK 740 million). For the first half of 2023 net profit amounted to USD 258 million (approx. DKK 1.8 billion). Cash flow from operating activities in Q2 amounted to USD 201 million (approx. DKK 1.4 billion). For the first half of 2023, cash flow from operating activities amounted to USD 347 million (approx. DKK 2.4 billion). Return on equity (annualised) was 30% at the end of Q2 and was 36% for the first half of 2023. Based on year-to-date net income of USD 258 million and high

BioStock: Respiratorius’ CEO comments on the second quarter

The process to reach a partnership deal continued for Respiratorius during the second quarter. At the same time, the company continues to build on the VAL001 project, and were able to present results from a collaboration with the University of North Carolina during the period. BioStock contacted CEO Johan Drott to find out more.Read the full article at biostock.se : https://www.biostock.se/en/2023/08/respiratorius-ceo-comments-on-the-second-quarter/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

The Board of Directors of Relais Group Plc decided on new stock option plans

Relais Group PlcStock Exchange Release 10 August 2023 at 9:15 a.m. EEST   The Board of Directors of Relais Group Plc has decided to launch two new stock option plans for key employees. The company has a weighty financial reason for the issue of stock options, since the stock options are intended to form part of the Group's incentive and commitment program for the key employees. The purpose of the stock options is to encourage the key employees to work on a long-term basis in order to increase shareholder value. In addition, the stock options aim to commit the key employees to the

XNK Therapeutics enters into agreement with US-based biotechnology company

XNK Therapeutics AB (“XNK”) today announced that the company has entered into an agreement with a US biotechnology company. Under the agreement the parties will perform preclinical evaluation of XNK’s autologous NK cell therapy candidate XNK02 in combination with a drug candidate currently in clinical development by the US company. The combination will initially be tested against acute myeloid leukemia (AML). The collaboration supplements XNK’s current collaborations in the field of AML with the University of Texas MD Anderson Cancer Center. For more information, please contact:

Invitation to presentation of Pagero’s interim report for Q2 2023

Pagero Group AB (publ) publishes interim report for January – June 2023 on 24 August 2023 at 07.30 CET and invites to a presentation of the report at 09.00 CET on the same day.Bengt Nilsson, CEO of Pagero, will present Pagero’s first half year in a webcast. It will be possible to submit questions in writing during the presentation, which will be answered at the end of the broadcast. Follow the presentation live: Link  For more informationOscar Wegland, CMOOscar.wegland@pagero.com About Pagero

There are no items matching the current filter
There are no more items matching the current filter
Back to top